-
Worth Watching Stocks: Cytokinetics, Incorporated (NASDAQ:CYTK), American Airlines Group Inc. (NASDAQ:AAL), Taylor Morrison Home Corporation (NYSE:TMHC), Semtech Corporation (NASDAQ:SMTC), Providence Service (NASDAQ:PRSC)
Cytokinetics, Incorporated (NASDAQ:CYTK) announced that the Company`s President and CEO, Robert Blum, received the 2014 Lou Gehrig Iron Horse Award from ALS Therapy Development Institute (ALS.net) at the Fourth Annual A White Coat Affair Gala on Saturday, November 8, 2014. Cytokinetics, Incorporated (NASDAQ:CYTK) in last trading activity moved down -2.75% to close at $4.24. Company…
-
Traders Are Watching: Staples (NASDAQ:SPLS), FireEye (NASDAQ:FEYE), Cytokinetics, Incorporated (NASDAQ:CYTK), Ubiquiti Networks (NASDAQ:UBNT), Planar Systems Inc. (NASDAQ:PLNR)
On October 20, Staples, Inc. (NASDAQ:SPLS) and designer Cynthia Rowley, today announce an exclusive work and home office collection that incorporates bold and artistic designs into everyday work and home spaces. Staples, Inc. (NASDAQ:SPLS) in last trading activity increased 0.47% to close at $12.91. Company weekly performance is 4.45% while its quarterly performance stands at…
-
Microcap Gainers: iBio (NYSEMKT:IBIO), YOU On Demand (NASDAQ:YOD), Cytokinetics (NASDAQ:CYTK), Entropic Communications (NASDAQ:ENTR), ITT Educational Services (NYSE:ESI)
Harwood Feffer LLP on Oct. 28 said it is investigating potential claims against the board of directors of iBio, Inc. (NYSEMKT:IBIO), concerning whether the board has breached its fiduciary duties to shareholders. On October 16, 2014, iBio issued a press release purporting to confirm that certain of its patents and proprietary technology could be used…
-
Biotech Gainers: iBio (NYSEMKT:IBIO), Cytokinetics (NASDAQ:CYTK), Vitae Pharmaceuticals (NASDAQ:VTAE), Kite Pharma (NASDAQ:KITE), Tokai Pharmaceuticals (NASDAQ:TKAI)
On 1st November Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. (NYSEMKT:IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company’s CEO. iBio, Inc. (NYSEMKT:IBIO) in last trading activity increased 10.19%…
